Exercise modulates central and peripheral inflammatory responses and ameliorates methamphetamine-induced anxiety-like symptoms in mice.
acute withdrawal
anxiety-like symptoms
cytokine
methamphetamine
microglia
neuroinflammation
treadmill exercise
Journal
Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
05
2022
accepted:
28
07
2022
entrez:
15
9
2022
pubmed:
16
9
2022
medline:
16
9
2022
Statut:
epublish
Résumé
Anxiety-like symptoms are common symptoms of methamphetamine (METH) users, especially in the acute withdrawal period, which is an important factor for the high relapse rate during METH acute withdrawal. Exercise has been demonstrated to relieve anxiety-like symptoms during METH withdrawal, but the underlying mechanisms of this anti-anxiety effect are still unclear. Activated microglia and abnormal neuroinflammation play an important role in the pathogenesis of anxiety-like symptoms after METH withdrawal. Moreover, peripheral immune factors were also significantly associated with anxiety symptoms. However, the effects of treadmill exercise on microglial function and neuroinflammation in the striatum and hippocampus during acute METH withdrawal have not been reported. In the current study, we found severe peripheral immune dysfunction in METH users during acute withdrawal, which may in part contribute to anxiety symptoms during METH acute withdrawal. We also showed that 2 weeks of METH exposure induced anxiety-like symptoms in the acute withdrawal period. Additionally, METH exposure resulted in increased microglial activation and proinflammatory cytokines released in the mouse striatum and hippocampus during acute withdrawal. We next evaluated the effects of treadmill exercise in countering anxiety-like symptoms induced by METH acute withdrawal. The results showed that anxiety-like symptoms induced by acute METH withdrawal were attenuated by coadministration of treadmill exercise. In addition, treadmill exercise counteracted METH-induced microglial activation in the mouse striatum and various subregions of the hippocampus. Furthermore, treadmill exercise also reversed the increase in proinflammatory cytokines induced by acute METH withdrawal in the mouse striatum, hippocampus and serum. Our findings suggest that the anti-anxiety effect of treadmill exercise may be mediated by reducing microglial activation and regulating central and peripheral inflammatory responses.
Identifiants
pubmed: 36106141
doi: 10.3389/fnmol.2022.955799
pmc: PMC9465459
doi:
Types de publication
Journal Article
Langues
eng
Pagination
955799Informations de copyright
Copyright © 2022 Re, Li, Yang, Li, Zhang, Wu, Zhou, Kong, Luo, Kuang and Wang.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Addiction. 2006 Oct;101(10):1473-8
pubmed: 16968349
Atherosclerosis. 2005 Sep;182(1):1-15
pubmed: 15904923
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Dec 20;111:110109
pubmed: 32941923
Int J Obes (Lond). 2017 Aug;41(8):1237-1245
pubmed: 28465604
Addiction. 2007 Apr;102 Suppl 1:16-32
pubmed: 17493050
Ann Neurol. 1991 Oct;30(4):572-80
pubmed: 1789684
J Subst Abuse Treat. 2016 Dec;71:16-22
pubmed: 27776672
J Pharmacol Exp Ther. 2004 Oct;311(1):1-7
pubmed: 15163680
Maturitas. 2017 Dec;106:48-56
pubmed: 29150166
Addict Biol. 2022 Jan;27(1):e13068
pubmed: 34128302
Therap Adv Gastroenterol. 2021 Aug 31;14:17562848211033763
pubmed: 34484421
Neuropsychopharmacology. 2021 Dec;46(13):2358-2370
pubmed: 34400780
Am J Drug Alcohol Abuse. 2015 Jan;41(1):7-15
pubmed: 25397661
Cell. 2019 Feb 21;176(5):1143-1157.e13
pubmed: 30794775
J Proteome Res. 2019 Nov 1;18(11):3913-3925
pubmed: 31525931
J Neuroinflammation. 2018 Dec 12;15(1):341
pubmed: 30541633
Pharmacol Res. 2017 Jun;120:60-67
pubmed: 28302577
Front Psychiatry. 2015 Dec 18;6:178
pubmed: 26732994
J Vis Exp. 2018 Jun 5;(136):
pubmed: 29939190
JAMA Psychiatry. 2020 Mar 1;77(3):246-255
pubmed: 31825466
Neurotox Res. 2020 Mar;37(3):640-660
pubmed: 31900895
Neuropsychobiology. 2017;75(4):169-177
pubmed: 29402784
Subst Abus. 2020;41(4):493-500
pubmed: 31638882
Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165823
pubmed: 32360589
Biomed Res Int. 2017;2017:7949582
pubmed: 28913358
Annu Rev Physiol. 2017 Feb 10;79:619-643
pubmed: 27959620
Am J Addict. 2010 Sep-Oct;19(5):385-90
pubmed: 20716300
Cochrane Database Syst Rev. 2009 Apr 15;(2):CD003021
pubmed: 19370579
Brain Behav Immun. 2022 Jan;99:70-82
pubmed: 34543680
Science. 2016 May 6;352(6286):712-716
pubmed: 27033548
Am J Psychiatry. 2010 Jan;167(1):17-23
pubmed: 20068123
Am J Transl Res. 2021 Mar 15;13(3):1779-1788
pubmed: 33841702
Nat Rev Neurosci. 2014 Mar;15(3):181-92
pubmed: 24552786
Front Pharmacol. 2021 Mar 17;12:619436
pubmed: 33815104
Cell Metab. 2018 Oct 2;28(4):656-666.e1
pubmed: 30017358
J Pharmacol Sci. 2022 Mar;148(3):326-330
pubmed: 35177212
Drug Chem Toxicol. 2022 Sep;45(5):2319-2327
pubmed: 34182834
Biol Psychol. 2018 Mar;133:79-84
pubmed: 29408464
J Clin Invest. 2020 Aug 3;130(8):4025-4038
pubmed: 32568214
Front Mol Neurosci. 2017 Dec 12;10:409
pubmed: 29311802
Glia. 2021 May;69(5):1155-1169
pubmed: 33314324
Medicine (Baltimore). 2017 Apr;96(15):e6434
pubmed: 28403074
J Neurosci. 2008 May 28;28(22):5756-61
pubmed: 18509037
Cell Stem Cell. 2022 Apr 7;29(4):620-634.e6
pubmed: 35245443
J Subst Abuse Treat. 2015 Oct;57:36-40
pubmed: 25934458
Int J Environ Res Public Health. 2020 Apr 14;17(8):
pubmed: 32295141
Curr Neuropharmacol. 2018;16(5):574-582
pubmed: 28901278
Trends Neurosci. 2019 Sep;42(9):573-588
pubmed: 31362874
Trends Neurosci. 2015 Oct;38(10):637-658
pubmed: 26442697
Iran J Pharm Res. 2019 Fall;18(4):2067-2082
pubmed: 32184870
Int Rev Immunol. 2020;39(2):39-52
pubmed: 31682154
Nature. 2021 Dec;600(7889):494-499
pubmed: 34880498
J Vis Exp. 2015 Feb 06;(96):e52434
pubmed: 25742564
J Neuroinflammation. 2017 Dec 11;14(1):240
pubmed: 29228978
CNS Neurosci Ther. 2018 Feb;24(2):85-97
pubmed: 29266758
J Neuroinflammation. 2019 Jan 24;16(1):15
pubmed: 30678702
Front Psychiatry. 2020 Dec 11;11:594766
pubmed: 33362607
Mol Pharmacol. 2000 Dec;58(6):1247-56
pubmed: 11093760
JAMA Psychiatry. 2021 Dec 1;78(12):1329-1342
pubmed: 34550301
Front Endocrinol (Lausanne). 2022 Jan 03;12:801686
pubmed: 35046900
JAMA Psychiatry. 2013 Mar;70(3):319-24
pubmed: 23303471
Mol Psychiatry. 2014 Jun;19(6):699-709
pubmed: 24342992
Neurochem Int. 2021 Sep;148:105121
pubmed: 34224806
J Psychiatr Res. 2015 Dec;71:48-55
pubmed: 26522871
Front Mol Neurosci. 2020 Mar 06;13:20
pubmed: 32210759
Proc Natl Acad Sci U S A. 2020 Jan 21;117(3):1742-1752
pubmed: 31892541
Exp Neurol. 2004 May;187(1):47-57
pubmed: 15081587
Int J Mol Sci. 2020 Aug 21;21(17):
pubmed: 32839415
Front Psychiatry. 2021 Aug 25;12:721999
pubmed: 34512420
Nat Rev Neurol. 2021 Mar;17(3):157-172
pubmed: 33318676
Chemosphere. 2022 Mar;291(Pt 2):132982
pubmed: 34822863
Nature. 2016 Feb 11;530(7589):219-22
pubmed: 26840481
FASEB J. 2019 Jul;33(7):8648-8665
pubmed: 30995872
Curr Neuropharmacol. 2018;16(5):533-558
pubmed: 29173175
Neurotox Res. 2020 Jan;37(1):67-76
pubmed: 31691188
Cureus. 2021 Sep 20;13(9):e18138
pubmed: 34692346
Neurotox Res. 2011 Jul;20(1):59-68
pubmed: 20953917
JAMA Psychiatry. 2018 Nov 1;75(11):1199-1201
pubmed: 30208372
Int J Mol Sci. 2021 Dec 29;23(1):
pubmed: 35008791
BMC Immunol. 2016 Apr 23;17(1):7
pubmed: 27107567
Neurotoxicology. 2020 Mar;77:20-28
pubmed: 31812708
Brain Behav Immun. 2019 Aug;80:247-254
pubmed: 30885840
J Neuroinflammation. 2018 Jan 17;15(1):21
pubmed: 29343269
Front Immunol. 2021 Aug 19;12:730300
pubmed: 34489980
Addict Biol. 2021 Nov;26(6):e13062
pubmed: 34114299
Cells. 2019 Jul 09;8(7):
pubmed: 31324021
Saudi Pharm J. 2020 May;28(5):621-629
pubmed: 32435144
Drug Alcohol Depend. 2021 Jun 1;223:108702
pubmed: 33894459
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):89-94
pubmed: 28899958
J Cardiopulm Rehabil Prev. 2007 Nov-Dec;27(6):359-67
pubmed: 18197069
Glia. 2019 Jun;67(6):1017-1035
pubmed: 30548343
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:199-206
pubmed: 30664970
Addiction. 2010 Oct;105(10):1809-18
pubmed: 20840201
Ann N Y Acad Sci. 2015 Mar;1337:1-6
pubmed: 25773610
Eur J Immunol. 2019 Jan;49(1):19-29
pubmed: 30407631
Brain Sci. 2019 Nov 25;9(12):
pubmed: 31775383
Front Psychiatry. 2020 Jan 28;10:999
pubmed: 32047445
Brain Behav Immun. 2021 Jan;91:505-518
pubmed: 33161163
J Alzheimers Dis. 2017;56(4):1469-1484
pubmed: 28157094
Mol Psychiatry. 2021 Nov;26(11):6187-6197
pubmed: 34686765
Hum Psychopharmacol. 2022 Jan;37(1):e2810
pubmed: 34432333
Mol Psychiatry. 2021 Apr;26(4):1194-1207
pubmed: 32051547
J Chem Neuroanat. 2017 Jul;82:5-11
pubmed: 28323108
J Vis Exp. 2008 Dec 22;(22):
pubmed: 19229173
Annu Rev Neurosci. 2010;33:173-202
pubmed: 20331363
Sci Transl Med. 2018 Oct 31;10(465):
pubmed: 30381407
PLoS Med. 2020 Jul 6;17(7):e1003172
pubmed: 32628679
Psychiatry Res. 2011 Apr 30;186(2-3):356-61
pubmed: 21055832
Transl Psychiatry. 2020 Jul 30;10(1):256
pubmed: 32732969